Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for determining related substances in Trelagliptin tablets

A technology related to substances and tablets, applied in the field of analytical chemistry, can solve the problem of impossible to completely control the quality of this product, and achieve the effect of solving the problem of separation and determination and controllable quality.

Active Publication Date: 2016-07-06
ZHONGSHAN WANHAN PHARM CO LTD
View PDF4 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

All these aspects indicate that the previously disclosed analytical methods cannot completely control the quality of this product

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for determining related substances in Trelagliptin tablets
  • Method for determining related substances in Trelagliptin tablets
  • Method for determining related substances in Trelagliptin tablets

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Instruments and experimental conditions:

[0038] High performance liquid chromatography: Shimadzu LC-16,

[0039] Chromatographic column: XselectC18 (Waters, 150×4.6mm, 3.5um),

[0040] Mobile phase A is phosphoric acid aqueous solution, pH=2.0, mobile phase B is acetonitrile; linear gradient elution according to Table 2.

[0041]

[0042]

[0043] The flow rate is 1.2mL / min,

[0044] Column temperature 35°C,

[0045] Detection wavelength 224nm,

[0046] The injection volume was 10 μl.

[0047] Experimental steps:

[0048] Take the blank solution and the impurity reference substance solution respectively, carry out high-performance liquid chromatography analysis according to the above experimental conditions, and record the chromatograms. The results are shown in the attached figure 1 And attached figure 2 , API in the figure represents Trexagliptin.

[0049] figure 2 In the middle is the chromatogram corresponding to trexagliptin and each known impurit...

Embodiment 2

[0051] Instruments and experimental conditions:

[0052] High performance liquid chromatography: Shimadzu LC-16,

[0053] Chromatographic column: XselectC18 (Waters, 150×4.6mm, 3.5um),

[0054] Mobile phase A is phosphoric acid aqueous solution, pH 2.0, mobile phase B is acetonitrile; linear gradient elution according to Table 3.

[0055]

[0056]

[0057] The flow rate is 1.2mL / min,

[0058] Column temperature 35°C,

[0059] Detection wavelength 224nm,

[0060] The injection volume was 10 μl.

[0061] Experimental steps:

[0062] Get Trexagliptin tablet sample powder 49.42mg (containing Trexagliptin 24.99mg), put in the 50ml measuring bottle, be 10% acetonitrile dissolving sample with volume percentage, be mixed with every 1mL containing Trexagliptin 0.988mg sample solution.

[0063] Get impurity reference substance solution and trexagliptin tablet sample solution respectively, carry out high performance liquid chromatography analysis by above-mentioned experimental...

Embodiment 3

[0067] Instruments and experimental conditions:

[0068] High performance liquid chromatography: Shimadzu LC-16,

[0069] Chromatographic column: CortecsC18 (Waters, 150×4.6mm, 2.7um),

[0070] Mobile phase A is phosphoric acid aqueous solution, pH=2.0, mobile phase B is acetonitrile solution; linear gradient elution according to Table 5.

[0071]

[0072]

[0073] The flow rate is 1.2mL / min

[0074] Column temperature 35°C

[0075] Detection wavelength 224nm

[0076] The injection volume was 10 μl.

[0077] Experimental steps:

[0078] Take trexagliptin tablet sample powder 50.68mg (containing trexagliptin 25.02mg), put in a 50ml measuring bottle, dissolve the sample with 10% acetonitrile, and be prepared into a sample solution containing trexagliptin 1.01mg per 1mL.

[0079] Take impurity reference substance solution and trexagliptin tablet sample solution respectively, carry out high performance liquid chromatography analysis according to above-mentioned experime...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention provides a method for determining related substances in Trelagliptin tablets, and relates to the field of analytical chemistry. The method comprises the steps that a high-performance liquid chromatography method is adopted, a sample solution is injected into a high-performance liquid chromatographic instrument, determination of the related substances in the Trelagliptin tablets is completed, and the chromatographic conditions are that a chromatographic column takes silica gel of which the surface is provided with electric hybrid particles as a filler, a mobile phase A is an acidic aqueous solution, a mobile phase B is an organic solvent, the sum of the volume percent of the mobile phase A and the volume percent of the mobile phase B maintains 100% all the time, and linear gradient elution is conducted. According to the method for determining the related substances in the Trelagliptin tablets, an Xselect C18 chromatographic column is adopted, optimization is conducted on the mobile phase gradient elution program, and the related substances in the Trelagliptin tablets can be effectively separated. The separation determination problem of the related substances in the Trelagliptin tablets is solved, and therefore it is guaranteed that the quality of the Trelagliptin tablets is controllable.

Description

technical field [0001] The invention relates to the field of analytical chemistry, in particular to a method for determining related substances in trexagliptin tablets. Background technique [0002] Among the antidiabetic drugs, the research of orally administered small molecule DPP-IV inhibitors is the most active. DPP-IV is an enzyme in the body that triggers the inactivation of incretins, glucone-like peptide-1 and glucose-dependent insulinotropic polypeptide, two incretins that play an important role in blood glucose regulation . Inhibition of DPP-IV can increase blood glucose level-dependent insulin secretion, thereby controlling blood glucose levels. [0003] DPP-IV inhibitor drugs are named "gliptins". There are 17 such drugs. Among them, trexagliptin was developed by Takeda Pharmaceutical and was first approved for marketing in Japan in 2014. It is an ultra-long-acting The DPP-IV inhibitor only needs to be taken orally once a week, which can produce continuous DPP...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N30/02
CPCG01N30/02G01N2030/027
Inventor 杜志博王鹤然陈嘉智邵诗雅徐小林彭韪
Owner ZHONGSHAN WANHAN PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com